pharmatechoutlook

Making the Move to Virtual and Hybrid Clinical Trials

By Pharma Tech Outlook | Tuesday, January 08, 2019

Virtual trials offer multiple modalities to engage patients and can be used on the device by any clinical trials. This new technology makes it easier to conduct trials as patients demand more flexibility to participate in trials. This new way of doing business is becoming more attractive and prevalent.

Trial sites remain an important and essential component of clinical trials. The choice of conducting a virtual trial brings patient engagement, cost efficiencies, improved data gathering, and empowered research teams.

Virtual trials have a patient-centric appeal over traditional clinical trials. They eliminate travel time to trial sites and provide a safer and more comfortable space to receive treatment. Patients with mobility issues are also granted greater access to trials when they are virtual. This allows the patients to participate in trials from the comfort of their homes. This makes them more willing to participate and allows greater access to an increased number of patients by medical practitioners and trial staff. With patients at home makes it easier for trial staff to fit into their daily lives guarantees patient retention and trial compliance.

The cost savings are also a major benefit as the trial staff will be based at a single trial site or reduced number of sites. This makes the operating costs significantly lower. The technology of virtual trials also benefits to the research team with notifications, scheduling and reporting functions, makes researchers freed from performing tedious administrative tasks. Trail managers could recruit participants through social media platforms and online advertisements. Provided with smartphones can help patients communicate to trial staff through video conferencing.

The benefits can be listed as below:

a) modern research experience for patients and sites

b) reduced research costs

c) accelerated timelines

d) continuous data collection

e) value and support specific to the patients

f) instant continuous view of patient data

g) decreased onsite visits and increased interaction

h) reduced administrative burden

There are also risks associated with virtual clinical trials like less face-to-face interaction or in-person interaction, the technology learning curve, and requirement of revised standard operating procedures.

New Editions